Beam Therapeutics Inc (BEAM)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
2,506,792,000
EV to revenue ratio (TTM)
10.32
EV to ebitda
-7.03
Financial Performance
Revenue (TTM)
156,035,000
Gross profit (TTM)
-252,628,992
EBITDA
-355,780,992
Profitability
Operating margin (TTM)
-25,827.00%
Profit margin
-55.40%
Return on assets (TTM)
-17.00%
Return on equity (TTM)
-8.18%
Per Share Metrics
Revenue per share (TTM)
1.51
EPS
-0.69
Diluted EPS (TTM)
-0.69
Book value
10.69
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
16.07
Price to book ratio (TTM)
2.357
Growth
Quarterly earnings growth (YoY)
-94.20%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
12
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.226